ArticleFrontiers in nutrition2025
Different association between triglyceride-glucose index and mild cognitive impairment in type 2 diabetes mellitus patients with and without diabetic kidney disease.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- TyG index and mild cognitive impairment and dementia: a review of current evidence.Frontiers in aging neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: The triglyceride-glucose (TyG) index, a surrogate marker reflecting metabolic status related to both glucose and lipid homeostasis, has been implicated in the development of diabetes-related complications, including diabetic kidney disease (DKD). Metabolic disturbances in carbohydrate and lipid pathways have also been linked to impairments in cognitive performance. This study aims to explore the association between TyG levels and the presence of mild cognitive impairment (MCI) among individuals with type 2 diabetes mellitus (T2DM), stratified by DKD status. Methods: A total of 243 patients with T2DM were divided into two subgroups based on cognitive status: those with MCI and those without. Clinical parameters were assessed and compared between the two cohorts. The association between TyG index and cognitive function was analyzed. Furthermore, potential predictors of MCI were explored separately in T2DM patients with and without DKD. Results: In individuals with T2DM, those exhibiting MCI ( Conclusion: Elevated TyG index levels have been linked to an increased likelihood of MCI, particularly affecting executive function and immediate recall, among individuals with T2DM but without DKD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.